Vakiti Pharmaceauticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.54 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
About Vakiti Pharmaceauticals
Vakiti Pharmaceauticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 2022 (Three years and one month 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.54 M.
The company currently has active open charges totaling ₹1.00 Cr.
Bakka Ashwini and Dharma Bakka serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299TG2022PTC158479
-
Company No.
158479
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jan 2022
-
Date of AGM
19 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vakiti Pharmaceauticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bakka Ashwini
|
Director | 09-Dec-2022 | Current |
|
Dharma Bakka
|
Director | 01-Mar-2024 | Current |
Financial Performance of Vakiti Pharmaceauticals.
Vakiti Pharmaceauticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vakiti Pharmaceauticals?
Unlock access to Vakiti Pharmaceauticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
S D Life Sciences India Private LimitedBakka Ashwini and Dharma Bakka are mutual person
-
Aditus Laboratories Limited
Bakka Ashwini is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2024 | State Bank Of India | ₹1.00 Cr | Open |
How Many Employees Work at Vakiti Pharmaceauticals?
Vakiti Pharmaceauticals has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vakiti Pharmaceauticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vakiti Pharmaceauticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
